Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer

被引:97
作者
Bristow, RE
del Carmen, MG
Kaufman, HS
Montz, FJ
机构
[1] Johns Hopkins Med Inst, Kelly Gynecol Oncol Serv, Dept Gynecol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Kelly Gynecol Oncol Serv, Dept Obstet & Oncol, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA
关键词
D O I
10.1016/S1072-7515(03)00478-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The aim of this study was to describe the feasibility, associated morbidity, and efficacy of radical oophorectomy with primary stapled colorectal anastomosis among patients with locally advanced ovarian cancer with contiguous extension to or encasement of the reproductive organs, pelvic peritoneum, cul-de-sac, and sigmoid colon. STUDY DESIGN: Thirty-one consecutive patients undergoing radical oophorectomy as part of an initial maximal surgical effort for International Federation of Obstetrics and Gynecology (FIGO) stage IIIB-IV ovarian cancer were prospectively collected from October 1, 1997 through November 30, 2001. The surgical technique, associated morbidity, and clinical outcomes are described. RESULTS: The median age was 63 years. All patients had advanced-stage epithelial ovarian cancer: FIGO stage IIIB (6.5%), stage IIIC (64.5%), stage IV (29.0%). Median operating time was 240 minutes (range 165 to 330 minutes), and the median estimated blood loss was 700 mL (range 300 to 2,900 mL).. All patients underwent en bloc rectosigmoid colectomy with primary stapled anastomosis without protective intestinal diversion. There was one (3.2%) anastomotic breakdown requiring reoperation and colostomy. Complete clearance of macroscopic pelvic disease was achieved in all cases. Overall, 87.1% of patients were left with optimal (:51 cm) residual disease and 61.3% were visibly disease free. There were no postoperative deaths, but major and minor postoperative morbidity occurred in 12.9% and 35.5% of patients, respectively. Blood product transfusion was required in 29.0% of cases: Thirty patients received multiagent platinum-based chemotherapy, with a median overall survival time of 39.5 months. CONCLUSIONS: Radical oophorectomy with primary stapled anastomosis is an effective technique for resection of locally advanced ovarian cancer and contributes significantly to a maximal cytoreductive surgical effort. The associated morbidity is acceptable, and protective intestinal diversion appears unnecessary. (C) 2003 by the American College of Surgeons.
引用
收藏
页码:565 / 574
页数:10
相关论文
共 40 条
[1]  
Announcements, 1989, Gynecologic Oncology, V35, P125, DOI [DOI 10.1016/0090-8258(89)90027-9, 10.1016/0090-8258(89)90027-9]
[2]  
BARBER HRK, 1965, SURGERY, V58, P935
[3]   Solid-phase synthesis of cyclic imides [J].
Barn, DR ;
Morphy, JR .
JOURNAL OF COMBINATORIAL CHEMISTRY, 1999, 1 (02) :151-156
[4]   The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma [J].
BenedettiPanici, P ;
Maneschi, F ;
Scambia, G ;
Cutillo, G ;
Greggi, S ;
Mancuso, S .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (04) :532-538
[5]  
BEREK JS, 1984, OBSTET GYNECOL, V64, P715
[6]   TUMOR REDUCTION SURGERY AND LONG-TERM SURVIVAL IN ADVANCED OVARIAN-CANCER - A DACOVA STUDY [J].
BERTELSEN, K .
GYNECOLOGIC ONCOLOGY, 1990, 38 (02) :203-209
[7]   EN-BLOC RESECTION OF EPITHELIAL OVARIAN-TUMORS WITH CONCOMITANT RECTOSIGMOID COLECTOMY - THE KEMH EXPERIENCE [J].
BRIDGES, JE ;
LEUNG, Y ;
HAMMOND, IG ;
MCCARTNEY, AJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (04) :199-202
[8]   Identification of prognostic factors in advanced epithelial ovarian carcinoma [J].
Chi, DS ;
Liao, JB ;
Leon, LF ;
Venkatraman, ES ;
Hensley, ML ;
Bhaskaran, D ;
Hoskins, WJ .
GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :532-537
[9]   The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy [J].
Clayton, RD ;
Obermair, A ;
Hammond, IG ;
Leung, YC ;
McCartney, AJ .
GYNECOLOGIC ONCOLOGY, 2002, 84 (01) :53-57
[10]  
Dauplat J, 2000, SEMIN SURG ONCOL, V19, P42, DOI 10.1002/1098-2388(200007/08)19:1<42::AID-SSU7>3.0.CO